11 Patent Results (6 families)
Make Note

Immunomodulating Compositions, Uses Therefor And Processes For Their Production

  • Published: Mar 9, 2011
  • Filed: Jun 10, 2004
  • Earliest Priority: Jun 10 2003
  • Family: 10
  • Cited Works: 170
  • Cited by: 2
  • Cites: 7
  • Sequences: 2232
  • Additional Info: Cited Works Published Sequence
  • Applicant: Opal Therapeutics Pty Ltd
Patent Application
EP 2292642 A1
010-207-904-650-163

Method For Isolating Bdca-4+ Dendritic Cells

  • Published: May 22, 2012
  • Filed: Mar 29, 2006
  • Earliest Priority: Nov 15 1999
  • Family: 7
  • Cited Works: 99
  • Cited by: 0
  • Cites: 62
  • Sequences: 38
  • Additional Info: Cited Works Full text Published Sequence
  • Applicant: Schmitz Juergen, Buck David William, Dzionek Andrzej, Miltenyi Biotec Gmbh
Granted Patent
US 8183039 B2
125-405-718-336-151

Discovery Of Regulatory T Cells Programmed To Suppress An Immune Response

  • Published: Apr 26, 2012
  • Filed: Oct 18, 2011
  • Earliest Priority: Oct 22 2010
  • Family: 12
  • Cited Works: 47
  • Cited by: 3
  • Cites: 4
  • Sequences: 1
  • Additional Info: Cited Works Full text Published Sequence
  • Applicant: Dana Farber Cancer Inst Inc, Cantor Harvey, Kim Hye-jung, Lu Linrong
Patent Application
WO 2012/054509 A2
083-664-717-608-770

Compositions For Stimulation Of Mammalian Innate Immune Resistance To Pathogens

  • Published: Nov 11, 2014
  • Filed: Mar 25, 2010
  • Earliest Priority: Mar 25 2009
  • Family: 37
  • Cited Works: 102
  • Cited by: 2
  • Cites: 100
  • Sequences: 3
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: The Board Of Regents The University Of Texas System
  • Applicant: Dickey Burton, Tuvim Michael, Evans Scott, Univ Texas
Granted Patent
US 8883174 B2
198-057-541-417-879

Compositions For Stimulation Of Mammalian Innate Immune Resistance To Pathogens

  • Published: Nov 17, 2015
  • Filed: Oct 21, 2014
  • Earliest Priority: Mar 25 2009
  • Family: 37
  • Cited Works: 100
  • Cited by: 1
  • Cites: 100
  • Sequences: 6
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: The Board Of Regents The University Of Texas System
  • Applicant: Univ Texas
Granted Patent
US 9186400 B2
199-056-708-790-117

Compositions For Stimulation Of Mammalian Innate Immune Resistance To Pathogens

  • Published: Nov 29, 2016
  • Filed: Sep 23, 2015
  • Earliest Priority: Mar 25 2009
  • Family: 37
  • Cited Works: 99
  • Cited by: 0
  • Cites: 100
  • Sequences: 6
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: The Board Of Regents The University Of Texas System
  • Applicant: Univ Texas
Granted Patent
US 9504742 B2
001-786-139-046-251

Discovery Of Regulatory T Cells Programmed To Suppress An Immune Response

  • Published: Jul 24, 2019
  • Filed: Oct 18, 2011
  • Earliest Priority: Oct 22 2010
  • Family: 12
  • Cited Works: 47
  • Cited by: 0
  • Cites: 12
  • Sequences: 1
  • Additional Info: Cited Works Published Sequence
  • Applicant: Dana Farber Cancer Inst Inc
Patent Application
EP 3514170 A1
100-341-187-845-629

Ligating Bdca-2 Protein With Bdca-2 Specific Antibody For Detecting Or Modulating Dendritic Cells

  • Published: Sep 10, 2019
  • Filed: Apr 23, 2012
  • Earliest Priority: Nov 15 1999
  • Family: 7
  • Cited Works: 229
  • Cited by: 0
  • Cites: 62
  • Sequences: 38
  • Additional Info: Cited Works Full text Sequence
  • Owner: Miltenyi Biotech Gmbh
  • Applicant: Schmitz Juergen, Dzionek Andrzej, Buck David William, Miltenyi Biotech Gmbh
Granted Patent
US 10407486 B2
076-285-430-586-777

Cd40 Agonist Antibody/type1 Interferon Synergistic Adjuvant Combination, Conjugates Containing And Use Thereof As A Therapeutic To Enhance Cellular Immunity

  • Published: May 8, 2013
  • Filed: May 3, 2007
  • Earliest Priority: May 03 2006
  • Family: 25
  • Cited Works: 53
  • Cited by: 0
  • Cites: 11
  • Sequences: 5
  • Additional Info: Cited Works Published Sequence
  • Applicant: Univ Colorado Regents
Patent Application
EP 2589654 A1
015-088-350-580-740

Cd40 Agonist Antibody/type1 Interferon Synergistic Adjuvant Combination, Conjugates Containing And Use Thereof As A Therapeutic To Enhance Cellular Immunity

Patent Application
WO 2007/130493 A2
143-515-853-713-749
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}} {{::'analysis.preview.view.full' | message}}

Add New Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save
Search ORCID

Sign in to the Lens

Forgot Password? Register New Account
Feedback